The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end

Fri, 16th Dec 2022 21:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Pearson PLC - London-based education publisher - Notes that Pearson Funding completed the redemption of its USD94.2 million principal amount outstanding of its 3.3% guaranteed notes due 2023 at a redemption price of USD1,003. The notes were guaranteed by Pearson PLC.

----------

Bank of Cyprus Holdings PLC - Nicosia-based lender - Extends the appointment of its group chief executive officer Panicos Nicolaou to December 31, 2026. Signs an amending agreement to his existing contract of employment which extends the period.

----------

Technology Minerals PLC - London-based company focused on creating a circular economy for battery metals - Draws down a GBP500,000 tranche from its GBP4.0 million convertible bond facility with Macquarie Bank Ltd and Atlas Capital Markets LLC.

----------

Anpario PLC - manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity - Receives an ISO 14001 certification. It is an internationally recognised standard for Environmental Management Systems. "We are pleased to have been accredited with ISO 14001 as this reflects our team's high operational standards which are focused on achieving our ambitious sustainability goals without negatively impacting our planet," Corporate Responsibility Director Karen Prior comments.

----------

Zanaga Iron Ore Company Ltd - iron ore exploration and development company - Completes the acquisition of a 50% plus one share interest in Jumelles Ltd. Appoints Peter Hill and Denis Weinstein to the board of the company.

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Enters into a clinical trial collaboration and supply agreement with Merck & Co for the supply of Keytruda, or pembrolizumab, an antibody used in cancer immunotherapy. "We are delighted to enter into a collaboration agreement with MSD for our ongoing PORCUPINE2 study to evaluate RXC004 in combination with their anti-PD-1 therapy, pembrolizumab. Biliary cancer is a devastating disease that is heavily reliant on Wnt signalling, so we are keen to explore the potential of combining RXC004 with ICIs. Our hypothesis, based on the preclinical data we have generated, is that when combined, there may be a greater chance of the patients showing an immune response, which we hope will lead to improved outcomes," Chief Medical Officer Jane Robertson says.

----------

Bushveld Minerals Ltd - South Africa-focused vanadium producer and energy storage provider - Says that Jacqueline Musiitwa will stand down as an Independent Non-Executive Director from the company's board effective immediately.

----------

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Gets "encouraging" initial results from an interim analysis conducted for the Refine-ALS prospective trial. It is a prospective, multicenter study sponsored by Mitsubishi Tanabe Pharma America. It is designed to identify biomarkers that could serve as quantifiable, biological and non-clinical measures of Edaravone's pharmacodynamic effect in Amyotrophic Lateral Sclerosis, a progressive nervous system disease.

----------

Uniphar PLC - Dublin-based healthcare business focusing on pharmaceutical and medical technology manufacturers - Reports that the Irish Competition & Consumer Protection Commission has not cleared its proposed acquisition of Dublin-based healthcare services provider Navi Group. States that the transaction will now no longer proceed to completion, as a result. The acquisition was first announced in December 2021.

----------

Beowulf Mining PLC - Natural resource developer and explorer focused on the Nordic region - Says its two new licenses at the Vardar lead-zinc-silver trend in Kosovo extend the coverage of Vardar's Mitrovica and Shala exploration projects. Adds that the two licences contain prospective "carbonate host rocks along with Oligocene magmatic rocks."

"The district being explored in northern Kosovo is highly prospective, with abundant evidence of widespread lead-zinc-silver mineralisation, and the addition of these new licences to Vardar's portfolio is a further exciting development. The Vardar team continues to use state-of-the-art exploration methodologies in the process of identifying new opportunities and is maintaining a competitive first-mover advantage in the region," CEO Kurt Budge says.

----------

PetroNeft Resources PLC - Ireland-based, Russian-focused oil and gas exploration and production company - Says that it is continuing to be in negotiations with Petrogrand AB regarding its loan facility. The facility has a current redemption value of USD2.5 million and matured on Thursday. "We cannot predict the outcome of these negotiations and the company will make further announcements in due course," the company states. In 2020 and 2021, PetroNeft extended its loan facility with Swedish firm Petrogrand AB.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 16:02

IN BRIEF: Redx Pharma shareholders approve AIM delisting plans

Redx Pharma PLC - clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve cancelling shares on AIM in London. This is now expected to take place on May 1, with last day of trading on April 30. Says it remains the company's intention to provide a matched bargain facility to assist shareholders wishing to trade in shares following the AIM delisting. Says it will make further details available in "due course" on its website.

Read more
12 Apr 2024 15:35

Director dealings: Redx Pharma CEO ups stake

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Read more
2 Apr 2024 16:57

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

Read more
2 Apr 2024 12:15

Redx Pharma plummets on plans to delist from AIM

(Alliance News) - Redx Pharma PLC shares fell on Tuesday, after it said it intends to cancel its shares from trading on AIM in London.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:50

AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2024 09:34

IN BRIEF: Redx Pharma clarifies not currently pursuing US listing

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Responds to a Times article published on Tuesday saying RedX is looking to list its shares in New York. Redx says it "wishes to clarify that it is not currently in any process relating to a listing in the US, nor any other jurisdiction".

Read more
7 Feb 2024 11:08

Redx Pharma shares skyrocket on deal to sell inhibitor program

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Read more
7 Feb 2024 09:29

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:30

Redx Pharma looks to progress portfolio after raising GBP14.1 million

(Alliance News) - Redx Pharma PLC on Wednesday said that it has conditionally raised around GBP14.1 million by way of a subscription for 54.1 million shares at 26 pence each.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:33

Redx Pharma says RXC007 receives orphan drug designation from US FDA

(Alliance News) - Redx Pharma PLC on Monday said its RXC007 drug has received orphan drug designation from the US Food & Drug Administration for the treatment of idiopathic pulmonary fibrosis, a condition causing breathing difficulty due to lung scarring.

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
10 Jul 2023 11:22

Redx Pharma extends term of outstanding notes with two lenders to 2024

(Alliance News) - Redx Pharma PLC on Monday said it extended the term of its outstanding convertible loan notes issued to two lenders RM Special Holdings 3 LLC, otherwise known as Redmile, and Sofinnova Crossover I SLP by a year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.